| Breakdown | Mar 2026 | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 5.89T | 5.52T | 5.26T | 5.00T | 4.48T |
| Gross Profit | 1.89T | 1.69T | 1.55T | 1.41T | 1.26T |
| EBITDA | 734.99B | 532.44B | 450.87B | 476.19B | 458.86B |
| Net Income | 407.70B | 324.08B | 284.95B | 213.91B | 203.48B |
Balance Sheet | |||||
| Total Assets | 7.36T | 6.38T | 6.17T | 5.58T | 5.11T |
| Cash, Cash Equivalents and Short-Term Investments | 731.61B | 757.33B | 765.38B | 645.87B | 727.18B |
| Total Debt | 363.28B | 462.29B | 501.29B | 505.05B | 394.71B |
| Total Liabilities | 2.73T | 2.30T | 2.30T | 2.22T | 2.01T |
| Stockholders Equity | 4.48T | 3.95T | 3.74T | 3.24T | 2.98T |
Cash Flow | |||||
| Free Cash Flow | 379.83B | 261.92B | 239.72B | -8.85B | 126.31B |
| Operating Cash Flow | 575.99B | 455.90B | 415.48B | 166.71B | 282.37B |
| Investing Cash Flow | -344.40B | -206.16B | -105.47B | -150.38B | -117.56B |
| Financing Cash Flow | -304.72B | -250.92B | -228.76B | -117.72B | -238.63B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | ¥2.21T | 23.21 | 12.05% | 1.50% | 9.27% | 3.50% | |
75 Outperform | ¥13.78T | 32.37 | 9.29% | 1.19% | 6.76% | 27.25% | |
70 Outperform | ¥657.99B | 15.72 | 9.63% | 2.12% | 4.94% | 37.62% | |
69 Neutral | ¥8.37T | 50.26 | 32.32% | 0.91% | 20.73% | 72.44% | |
68 Neutral | ¥3.66T | 50.53 | 10.06% | 1.21% | 8.80% | 117.61% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
62 Neutral | ¥1.88T | 53.05 | 8.39% | 1.49% | 0.83% | -37.84% |